Business Context and Reporting Period
This Form 6-K filing is submitted by pSivida Limited (not Eyepoint, Inc.) for the month of September 2005, with a report date of September 6, 2005. The registrant is a foreign issuer based in Perth, Western Australia, and files annual reports on Form 20-F.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of corporate events rather than a financial statement.
Material Changes and Corporate Events
The filing discloses two significant corporate developments via attached exhibits:
- Collaboration Agreement: A new collaboration with Cirrus Pharmaceuticals (Exhibit 99.1).
- Capital Raise: A Private Investment in Public Equity (PIPE) share issue (Exhibit 99.2).
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, or specific risk factors. The primary focus is the disclosure of the collaboration and share issuance.
Investor Verification Checklist
- Verify the terms and financial implications of the collaboration with Cirrus Pharmaceuticals.
- Confirm the size, pricing, and use of proceeds for the PIPE share issue.
- Review the full text of Exhibits 99.1 and 99.2 for detailed contractual obligations.